Editorial standards

Editorial policy & medical review

Every clinical article on primecellmed.com is reviewed and approved by a physician before it is published, cites primary sources, and says plainly what is FDA-approved, what is off-label and what is investigational. This page explains how that works — and how to tell us when we get something wrong.

Authorship

Who writes and who reviews

Short answer

Most clinical content is written by Kenny Chantasi, DO. Some patient-education articles are drafted by the PrimeCell editorial team; every one of them is medically reviewed and approved by Dr. Chantasi before publication. Every article names its writer and its medical reviewer, with the date it was last reviewed.

Physician author & reviewer
Kenny Chantasi, DO — founder and medical director of PrimeCell; board-certified in Physical Medicine & Rehabilitation and in Pain Medicine (AOBPMR); Florida osteopathic license OS22127.
Editorial team
Articles bylined “PrimeCell editorial team” are drafted by practice staff and medically reviewed and approved by Dr. Chantasi before publication, and the byline says so.
Byline
Each article shows “Written by”, “Medically reviewed by”, the publication date and the last-reviewed date.
Two audiences
The patient journal is written for patients. Long-form clinician-audience articles are currently being revised and are not published.

Medical review

How an article is reviewed

Dr. Chantasi reviews every clinical article on primecellmed.com before it goes live. Each one carries a “medically reviewed by” byline with the date of last review.

  1. Draft

    An article starts from a real patient question and is drafted by Dr. Chantasi or a contributing writer.

  2. Source check

    Every factual medical claim is matched to a primary source, and claims that cannot be sourced are removed or softened.

  3. Physician review

    Dr. Chantasi checks accuracy, regulatory labelling, risks and limitations, and approves the article — or sends it back.

  4. Publish & re-review

    The article is published with its review date and reviewed again when the evidence or regulatory status changes.

Source standards

What we cite, and what we do not

Articles cite primary sources wherever they make a factual medical claim, listed at the end of the article so you can check them yourself.

We cite

  • U.S. Food and Drug Administration guidance, approvals and safety communications
  • Official prescribing information (drug labels on DailyMed)
  • Peer-reviewed studies indexed in PubMed, with journal, year and DOI
  • Professional-society guidelines and position statements
  • Statutes and regulations, such as Florida law, when legal status matters

We avoid

  • Manufacturer marketing and press releases as evidence
  • Generic health blogs and uncited statistics
  • Presenting one small study as settled science
  • Citing a paper unless the authors, journal, year and identifier can be verified

Trial results are reported as trial results — what was studied, in whom, and what was found — and evidence is kept separate from clinical opinion.

Regulatory labelling

How FDA status is labelled

We say clearly which procedures and products are FDA-approved for a given use, and which are off-label, investigational or supported by limited evidence. The same three labels are used across the site.

  • FDA-approved

    The FDA has approved the product for this specific use after reviewing safety and effectiveness data.

  • Off-label / physician practice

    An approved drug, or a material prepared with an FDA-cleared device, used in a way the FDA has not specifically reviewed. Legal and common in medicine; evidence varies.

  • Not FDA-approved / investigational

    No FDA approval for this use. Regenerative options, including exosome and stem-cell-derived products, are described in line with their current regulatory status.

FDA status & Florida law, explained

Claims

No testimonials, no outcome claims

We do not publish guarantees about how well any treatment works.

  • No patient testimonials, reviews or star ratings on this site
  • No before-and-after photographs
  • No promises of pain relief, tissue regrowth, permanent results or specific weight loss
  • No outcome statistics until PrimeCell’s Outcomes Follow-Up program has followed enough patients, for long enough, to report honestly — it has no published results yet
  • Stock photography is never presented as PrimeCell patients, results or the clinic

Advertising & compliance

Florida notices on this site

This website is advertising for a medical practice as well as patient education, and it follows the Florida rules that apply to both.

Stem cell notice
Because Dr. Chantasi performs one or more stem cell therapies that are not FDA-approved, the notice required by Florida Statutes §458.3245 and §459.0127 appears on every page, set at the largest type size used on the page.
Reduced-fee notice
Whenever an introductory or reduced consultation fee is advertised, the patient notice required by Florida Statutes §456.062 appears with it.
Products
Cellular, tissue and exosome products are not advertised by brand or manufacturer; the specific product and its status are reviewed with a patient in writing before any procedure.
Not medical advice
Content on this site is general education and does not create a physician–patient relationship. Candidacy is determined at an individual evaluation.

Use of AI tools

Drafting tools

Drafting tools may be used; every clinical article is reviewed and approved by Dr. Chantasi before publication.

Tools are never the source of a medical claim: every claim must trace to a cited primary source, and responsibility for accuracy rests with the physician reviewer.

Corrections & updates

If something looks wrong or out of date

How to report it

Email info@primecellmed.com with the page address and what you believe is incorrect. Please do not include personal health information.

Review
Dr. Chantasi reviews each correction request against the sources.
Correction
Errors of fact are corrected and the article’s last-reviewed date is updated.
Update cadence
Articles are reviewed again when the evidence, a drug label or regulatory status changes, and clinical pages are checked at least once a year.

Questions about your own care belong in a consultation, not a correction request — call (407) 512-8878.

Education is general. Your evaluation is not.

When you are ready for an answer specific to you, start with a physician evaluation with Dr. Chantasi — in the office or by telemedicine.

Request a consultation Report a correction

2295 S Hiawassee Rd, Ste 103, Orlando · Mon–Fri 10–6

Call Request a consultation